MedTrace Logo

"Visiobiane Anti-age" Effects on Vision Parameters

NCT00449917 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2011-10-06

No results posted yet for this study

Summary

The purpose of this study is to determine the benefits of "Visiobiane Anti-age" dietary supplement on macular pigment optical density, contrast sensibility and visual acuity. Additionally, the study would like to evaluate seric variations of carotenoids and the total antioxydant capacity.

Conditions

  • Macular Pigment Optical Density

Interventions

DRUG

lutein

DRUG

DHA

DRUG

vitamins

Sponsors & Collaborators

  • PiLeJe

    lead INDUSTRY

Principal Investigators

  • Franck Bacin, MD · University Hospital, Clermont-Ferrand

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-09-30
Primary Completion
2007-07-31
Completion
2007-11-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00449917 on ClinicalTrials.gov